ZA200703562B - 1,5-diheterocycle-1H-triazole derivative - Google Patents

1,5-diheterocycle-1H-triazole derivative

Info

Publication number
ZA200703562B
ZA200703562B ZA200703562A ZA200703562A ZA200703562B ZA 200703562 B ZA200703562 B ZA 200703562B ZA 200703562 A ZA200703562 A ZA 200703562A ZA 200703562 A ZA200703562 A ZA 200703562A ZA 200703562 B ZA200703562 B ZA 200703562B
Authority
ZA
South Africa
Prior art keywords
diheterocycle
triazole derivative
triazole
derivative
Prior art date
Application number
ZA200703562A
Other languages
English (en)
Inventor
Kanaya Naoaki
Fujii Kunihiko
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of ZA200703562B publication Critical patent/ZA200703562B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200703562A 2004-10-19 2005-10-19 1,5-diheterocycle-1H-triazole derivative ZA200703562B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004303851 2004-10-19

Publications (1)

Publication Number Publication Date
ZA200703562B true ZA200703562B (en) 2008-08-27

Family

ID=36203009

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200703562A ZA200703562B (en) 2004-10-19 2005-10-19 1,5-diheterocycle-1H-triazole derivative

Country Status (13)

Country Link
US (1) US20080125409A1 (fr)
EP (1) EP1803719A4 (fr)
JP (1) JPWO2006043594A1 (fr)
KR (1) KR20070063530A (fr)
CN (1) CN101039934A (fr)
AU (1) AU2005296582A1 (fr)
CA (1) CA2583153A1 (fr)
IL (1) IL182538A0 (fr)
MX (1) MX2007004643A (fr)
NO (1) NO20071826L (fr)
RU (1) RU2007118659A (fr)
WO (1) WO2006043594A1 (fr)
ZA (1) ZA200703562B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05011276A (es) * 2003-04-21 2006-01-24 Daiichi Seiyaku Co Derivado heterociclico de cinco miembros.
KR102509043B1 (ko) 2014-06-06 2023-03-09 리써치 트라이앵글 인스티튜트 아펠린 수용체(apj) 효능제 및 이의 용도
WO2017100558A1 (fr) 2015-12-09 2017-06-15 Research Triangle Institute Agonistes améliorés du récepteur de l'apéline (apj) et leurs utilisations
AU2017343638B2 (en) * 2016-10-12 2021-12-09 Research Triangle Institute Heterocyclic apelin receptor (APJ) agonists and uses thereof
US20230416229A1 (en) * 2020-11-05 2023-12-28 Bayer Aktiengesellschaft [(1,5-diheteroaryl-1h-1,2,4-triazol-3-yl)oxy] acetic acid derivatives as safeners for the protection of useful plants and crop plants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR878201A0 (en) * 2001-11-09 2001-12-06 Fujisawa Pharmaceutical Co., Ltd. New compounds
WO2004060367A1 (fr) * 2002-12-30 2004-07-22 Fujisawa Pharmaceutical Co., Ltd. Derives d'imidazole et de triazole utiles en tant qu'inhibiteurs de cox-1 selectifs
TW200505447A (en) * 2003-02-07 2005-02-16 Daiichi Seiyaku Co Pyrazole derivative
MXPA05011276A (es) * 2003-04-21 2006-01-24 Daiichi Seiyaku Co Derivado heterociclico de cinco miembros.

Also Published As

Publication number Publication date
JPWO2006043594A1 (ja) 2008-05-22
KR20070063530A (ko) 2007-06-19
AU2005296582A1 (en) 2006-04-27
WO2006043594A1 (fr) 2006-04-27
NO20071826L (no) 2007-06-14
EP1803719A1 (fr) 2007-07-04
IL182538A0 (en) 2007-09-20
CN101039934A (zh) 2007-09-19
EP1803719A4 (fr) 2008-07-02
MX2007004643A (es) 2007-06-08
US20080125409A1 (en) 2008-05-29
CA2583153A1 (fr) 2006-04-27
RU2007118659A (ru) 2008-11-27

Similar Documents

Publication Publication Date Title
HUS1900034I1 (hu) 6,7-telítetlen-7-karbamoil-szubsztituált morfinán-származékok
ZA200606974B (en) Substituted 1,2,3,4-tetrahydrolsoquinoline derivatives
IL180331A0 (en) 3-carbamoyl - 2 - pyridone derivative
HK1091204A1 (en) Heteroarylcarbamoylbenzene derivative
HK1090368A1 (en) 2,3,6-trisubstituted-4-pyrimidone derivatives
IL176562A0 (en) Amidopyrazole derivative
EP1830858A4 (fr) 3,6-bicyclolides
ZA200506744B (en) PyrazoloÄ1,5-AÜpyrimidine derivatives
IL178166A0 (en) 1,3,4-oxadiazol-2-ones as ppar delta
AP2006003791A0 (en) 1-Heterocyclyl-1,5-dihydro-pyridoÄ3,2-BÜindol-2-ones
IL182538A0 (en) 1,5-diheterocycle-1h-triazole derivative
GB0507114D0 (en) No 1 timemachine
IL184677A0 (en) Substituted 1,1,1-trifluoro-3-[(benzyl)-
GB0425572D0 (en) 1,7-Naphthyridines
GB0403059D0 (en) Xigence version 1.0
GB0509703D0 (en) Hayfit 2
EP1711189A4 (fr) Derives d'azalide 8a 6,11-3c-bicyclique
IL188111A0 (en) 2,5-bis-diamimne [1,4] benzoquinone-derivatives
GB0514559D0 (en) Qmaster 2005
EP1940415A4 (fr) 19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamine d3
PL114818U1 (en) V .03
GB0417150D0 (en) Hydrodyne 2
AU2003280821A8 (en) Beauveriolide derivative
GB2423638B (en) Time-light 2000
PL368397A1 (en) M .511